Skip to main content

and
  1. No Access

    Article

    Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

    Targeting tyrosine kinase receptors that share the feedback inhibitor PTPN12 leads to broad spectrum therapeutic suppression of triple-negative breast cancer.

    Amritha Nair, Hsiang-Ching Chung, Tingting Sun, Siddhartha Tyagi in Nature Medicine (2018)